FDA 483 - Oklahoma Blood Institute Norman Center - March 22, 2019

The FDA inspected Oklahoma Blood Institute in Norman, OK, and issued a Form 483 with four observations. The inspection revealed significant issues with adherence to standard operating procedures, inadequate investigation of discrepancies, equipment control failures, and deficiencies in record-keeping practices. These findings indicate a lack of robust quality control and procedural compliance within the donor center.